KLOW (GHK-Cu + TB-500 + BPC-157 + KPV)

Blend of GHK-Cu, TB-500, BPC-157, and KPV

KLOW is a research blend combining GHK-Cu, TB-500, BPC-157, and KPV. Each of these compounds is individually studied in the scientific literature. This page is neutral background about the combination as a research material; it is not medical guidance, makes no claim of any combined or synergistic effect, and is not for human or veterinary use.

Classification and structure

This product is classified as a four-component peptide research blend. GHK-Cu is a copper-binding tripeptide, TB-500 is a synthetic thymosin beta-4 fragment, BPC-157 is a synthetic pentadecapeptide, and KPV is a short tripeptide (Lys-Pro-Val) derived from the C-terminal region of alpha-MSH. Each is a distinct chemical entity, individually researched, and combined strictly for laboratory research.

Areas of research

In the published literature, the individual components of this blend appear in the following research areas.

• Tissue and cellular research — GHK-Cu, TB-500, BPC-157, and KPV are each individually studied in laboratory models of tissue and cellular processes.
• Peptide and immunobiology research — KPV appears in alpha-MSH-related peptide research, while the other components appear in their own peptide-activity literature.

As always in this library, describing a compound as “studied in” an area is a statement about where scientific attention has gone — not a claim that it produces any result in humans or animals.

Handling and verification

Store lyophilized material cold and protected from light and moisture; reconstituted material has reduced stability. Every in-stock lot ships with a verifiable third-party Certificate of Analysis (COA).